CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Dilated cardiomyopathy: so many cardiomyopathies! Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction Mechanical circulatory support devices for acute right ventricular failure Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel

Review Articlev.10(8); 2021 Aug

JOURNAL:Cells. Article Link

Effect of SGLT2-Inhibitors on Epicardial Adipose Tissue: A Meta-Analysis

W Masson, A Lavalle-Cobo, JP Nogueira et al. Keywords: SGLT2-i; epicardial adipose tissue

Full Text PDF